pemetrexed (pemetrexed disodium) NDC 70710-1654

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1654Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1654Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1654-1	70710165401	1 VIAL in 1 CARTON (70710-1654-1) / 4 mL in 1 VIALMarketed from May 26, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): pemetrexed
Generic name (nonproprietary): pemetrexed disodium
Active ingredients: Pemetrexed disodium — 100 mg/4mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214073
Marketing start: May 26, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Folic Acid Metabolism Inhibitors (Mechanism)
Identifiers: Product ID 70710-1654_bf1de3fa-e7f8-4beb-beeb-6272709d13f2SPL ID bf1de3fa-e7f8-4beb-beeb-6272709d13f2SPL set ID 363665ca-db15-4123-84ac-0ae66b5f1363RxCUI 1728072, 1728077, 2601728UNII 2PKU919BA9UPC 0370710165512
Pharmacologic class: Folate Analog Metabolic Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470710165401 followed by a unit qualifier and the quantity

Package 70710-1654-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 26, 2022.

Indications (excerpt from the label)

Pemetrexed for injection, USP is a folate analog metabolic inhibitor indicated: in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations. ( 1.1 ) in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC). ( 1.1 ) as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. ( 1.1 ) as a single agent for the treatment of patients w…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214073

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214073
Product	Strength	Form · route	Labeler	Product NDC
pemetrexedpemetrexed disodium	Pemetrexed disodium 500 mg/20mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Lifesciences Limited	70771-1692
pemetrexedpemetrexed disodium	Pemetrexed disodium 100 mg/4mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Lifesciences Limited	70771-1691
pemetrexedpemetrexed disodium	Pemetrexed disodium 1000 mg/40mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Lifesciences Limited	70771-1693
pemetrexedpemetrexed disodium	Pemetrexed disodium 500 mg/20mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1655
pemetrexedpemetrexed disodium	Pemetrexed disodium 1000 mg/40mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1674